This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,400.96 Firm Fixed Price delivery order contract is for the supply of the medication LINZESS 145 MCG CAPSULE UU 30S. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,324.66 firm fixed price delivery order is for the supply of LINZESS 145 MCG capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,048.22 for the supply of LINZESS 145 MCG CAPSULE UU 30S. The contract is a firm-fixed-price award with an ultimate completion date of March 14, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. This award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,315.14 Firm Fixed Price delivery order is for the supply of LINZESS 290 MCG capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and...
This federal contract award, valued at $16,433.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the supply of LINZESS 72 MCG CAPSULE pharmaceutical products. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts to provide a wide range of prescription medications, medical supplies, and critical care materials to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,427.98 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S and has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,505.54 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has a completion date of December 9, 2022 and was awarded on December 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 290 MCG capsules. The $1,415.00 firm fixed price delivery order has an ultimate completion date of October 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.40 firm fixed-price delivery order is for LINZESS 145 MCG CAPSULE UU 30S, with a performance period ending on May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,443.80 firm fixed-price delivery order is for the supply of Linzess 290 MCG capsules. The contract has an ultimate completion date of February 9, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...